Abbreviated Title: AFED for the treatment of Ocular GVHD Version Date: 12SEP2017 Principal Investigator: Daniel Couriel, MD A RANDOMIZED, DOUBLE-BLINDED, PLACEBO-CONTROLLED STUDY FOR THE TREATMENT OF OCULAR CHRONIC GRAFT- VERSUS-HOST DISEASE (GVHD) WITH AMNIOTIC FLUID EYE DROPS (AFED) IRB # 103515 NCT # HCI-17-HEM-19 Principal Investigator Daniel Couriel, MD, MS Division of Hematology & Hematologic Malignancies Huntsman Cancer Institute - University of Utah 2000 Circle of Hope, Salt Lake City, UT 84112
[email protected] Sub-Investigators Catherine Lee, MD Division of Hematology & Hematologic Malignancies Huntsman Cancer Institute - University of Utah 2000 Circle of Hope Salt Lake City, UT 84112
[email protected] Michael Boyer, MD Department of Pediatrics, Primary Children’s Hospital Division of Hematology & Hematologic Malignancies Huntsman Cancer Institute - University of Utah 1950 Circle of Hope Salt Lake City, UT 84112
[email protected] Vedran Radjocic, MD Division of Hematology & Hematologic Malignancies Huntsman Cancer Institute - University of Utah 2000 Circle of Hope, Room 4246 Salt Lake City, UT 84112
[email protected] Axel Zander, MD Division of Hematology & Hematologic Malignancies Huntsman Cancer Institute - University of Utah 2000 Circle of Hope Salt Lake City, UT 84112
[email protected] Abbreviated Title: AFED for the treatment of Ocular GVHD Version Date: 12SEP2017 Sub-Investigators John Phillips, PhD Division of Hematology and Hematologic Malignancies University of Utah School